Federal Regulators Issue Notice to DTC Test Company Orig3n That Its Purchase of Interleukin Genetics Could Involve CLIA Compliance Issues

CMS sends letter to Orig3n notifying the genetic test company that it may not have the required certifications to market its genetic tests Orig3n’s recent ill-fated “DNA Day” promotion to offer free genetic tests during an NFL football game this past fall pushed Orig3n into the media spotlight. The Massachusetts-based biotech company—which sells 18 different […]

Source: Dark Daily - January 10, 2018 Category: Laboratory Medicine Authors: Jude Tags: Compliance, Legal, and Malpractice Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory News Laboratory Pathology Laboratory Testing anatomic pathology biomarkers centers for medicare and medicaid services CLI Source Type: news